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Abstract 
To date, antimicrobials have been primarily understood through largely biomedical perspectives. 
Antibiotics, for example, have been branded and consumed as miracle drugs. In this way there has 
been a tendency to focus upon the effectiveness of pharmaceuticals within individual bodies. 
However, the growing threat of antimicrobial resistance demands that we reconsider how we think 
about antimicrobials and their effects. Rather than understanding them primarily within bodies it is 
increasingly important to consider their effects between bodies, between species and across 
environments. We need to reduce the drivers of AMR at a global level, focussing on the connections 
between prescribing in one country and resistance mechanisms in another. We need to engage with 
the ways that antimicrobials within the food chain, or inside our domestic animals, can and will 
impact upon human health care. Moreover we need to realise what happens within the hospital 
ward can impact upon the environment. In the future imaginative interventions will be required to 
address such wicked problems. These interventions must make the most of biomedicine but draw 
equally across a wider range of disciplines (e.g., engineering, anthropology, ecologists) and include 
an ever increasing set of professionals (e.g., nurses, veterinarians, dentists and farmers). Such 
collective action demands a shift to working in new interdisciplinary and inter-professional ways. 
Mutual respect and understanding is required to enable each perspective to be combined to yield 
synergistic effects.  
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Introduction 
 
 ‘The time may come when penicillin can be bought by anyone in the shops. Then there is the 
danger that the ignorant man may easily underdose himself and by exposing his microbes to 
non-lethal quantities of the drug make them resistant. Here is a hypothetical illustration. Mr. 
X. has a sore throat. He buys some penicillin and gives himself, not enough to kill the 
streptococci but enough to educate them to resist penicillin. He then infects his wife. Mrs. X 
gets pneumonia and is treated with penicillin. As the streptococci are now resistant to 
penicillin the treatment fails. Mrs. X dies. Who is primarily responsible for Mrs. X’s death? 
Why Mr. X whose negligent use of penicillin changed the nature of the microbe’  
(Fleming, 1945: 93) 
 
 
 
The effectiveness of antimicrobials, such as antibiotics, has always been fraught with the 
threat of their failure. For antibiotics, from the very outset, there has been an 
acknowledgement of the interplay of biological, psychological and wider socio-cultural 
mechanisms in relation to effectiveness. In the quote above Fleming warned that biological 
resistance mechanisms are deeply inter-related to the actions of people (e.g., adherence 
and transmission behaviours). The extract also shows that such actions are loaded with 
morality and wider social significance (e.g., culpability). Such actions can also have profound 
consequences that include onwards transmission and even death.  
 
Reflecting upon the 72 years that have passed since Fleming gave this lecture, it is worth 
noting that biological and biomedical aspects of antimicrobials have been ascendant, with 
antibiotics for example, branded and widely consumed as ‘miracle drugs’ emblematic of the 
success of modern medicine. In stark contrast to these more biological aspects, the 
psychological and socio-cultural aspects of antimicrobials have largely been absent for much 
of this time. However now, as the threat of antimicrobial resistance (AMR) increases, and 
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antimicrobial development stalls, there is a growing need to engage and utilise these 
perspectives more fully.  
 
The growing threat of AMR 
There is a clear sense of the escalation of threat relating to AMR. Over the last few years 
there is a sense of momentum around the global threat of AMR. The growing sense of 
urgency in relation to AMR is palpable. In 2011, for example, World Health Organization’s 
Director General, Margaret Chan, described AMR as “one of the three greatest threats to 
human health”. In 2013, the United Kingdom’s Chief Medical Officer, Dame Sally Davies, was 
quoted to have said that antimicrobial resistance was a catastrophe equal to terrorism and 
climate change (McCarthy, 2013). AMR has recently been predicted to be the main cause of 
death for 10 million people globally each year by the year 2050 (Department of Health, 
2013). In 2015, AMR was listed on the United Kingdom’s National Risk Register of Civil 
Emergencies (Cabinet Office, 2015). The World Bank has warned that, by 2050, drug-
resistant infections could cause global economic damage on a par with the 2008 financial 
crisis. The potential economic cost of AMR by 2050 has been estimated to be around 
US$100 trillion (O'Neill, 2016).  
 
Conceptualising AMR as a key way of combatting AMR 
Economic factors block the development of many new antimicrobials.  In this way major 
biomedical solutions to the increasing AMR problem are unlikely. Furthermore, as Fleming 
outlined, they come with built in obsolescence as evolution drives the adaption of microbes 
to the new selective pressures associated with the drugs.  The lack of new antimicrobials 
5 
 
such as antibiotics has led to a focus on how we can conserve, or steward, the 
antimicrobials that are currently in existence. This has led to interdisciplinary research which 
has investigated the complex journey of our existing antimicrobials outside of the bodies in 
which their biomedical actions are intended are intended to work. There are a wealth of 
frameworks (Department of Health, 2014) available to help us understand these ecological, 
or One-health (European Commission, 2017)approaches to AMR (see Figure 1).   
 
These conceptualisations show, for example, how away from the hospital wards in which 
they are consumed antimicrobials can enter the environment through waste water 
(Baquero et al., 2008). Equally, the very same antimicrobial agents can exert equally 
complex and far reaching effects through their use in agriculture (Baquero et al., 2008) or 
indeed within domestic animals (Guardabassi et al., 2004). Moreover, it is now increasingly 
acknowledged that modern travel and other aspects of globalisation mean that 
pharmaceuticals as well as microbial life move readily across the globe (MacPherson et al., 
2009). Given the gross diversity in the regulation and consumption of antimicrobials across 
the world, interventions to reduce AMR must have global relevance. Ensuring effective 
interventions are in place within low and middle income countries is as important as 
ensuring there are effective interventions within the developed world.  
 
It is important to grapple with the systemic qualities of AMR. Without doing so can mean 
that effective interventions in one location can cause the system to adapt and create 
problems elsewhere. Effective interventions focusing upon the reduction of antibiotics 
within primary care for example, may well drive potential negative, unanticipated and 
remote effects elsewhere. These could include increasing the unregulated patient 
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consumption of internet-purchased antibiotics, or indeed poor compliance with drug 
regimes in order to retain and store for potential future use. Equally, interventions that 
restrict and severely regulate the use of third line antibiotics within human health care will 
not reduce the drivers of resistance to them if they are prescribed to domestic animals 
without such regulation. Such systemic conceptualisations of the drivers of AMR mean we 
need to be creative with how we use our research methods, for example, the way we 
measure outcomes within randomised controlled trials for example to assess remote and 
unanticipated negative effects.  
 
Figure 1 conceptualising complexity within AMR systems 
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What AMR asks of us as experts within infection prevention 
AMR demands to be understood and addressed outside of any particular species (e.g., 
human, pig or domestic cat), outwith any particular physical location (e.g., the hospital 
ward), across a variety of disciplinary lenses (e.g., psychology or engineering), between 
professional perspectives (e.g., nursing vs vet), across national borders (Scotland vs India). 
AMR also warrants an approach which is trans-generational and which frames the drivers of 
AMR as an inevitable and enduring process that is both complex and, as Figure 1 indicates, 
systemic.  
 
Beyond the adaptation of microbes to pharmaceuticals, the drivers of AMR are deeply 
multifaceted. They result from the actions of, and interactions between, microbes, more 
complex animal species, and within the human species, between governments, 
organisations, institutions, professionals and amongst the public, particularly when they 
become patients. Public health interventions rarely focus upon so many things at once; they 
rarely attempt to examine the connections between elements within complex and adaptive 
systems. Yet, this is exactly what the threat of AMR demands of us. We need to be creative 
with regard to the ways we consider our theories and methods. We need to be innovative in 
terms of interdisciplinary and transdisciplinary practice. The drivers of AMR are distributed 
across multiple and multi-layered stakeholders, from the role of an infection prevention and 
control nurse to a salmon farmer in the highlands of Scotland. AMR must be understood 
outside of any sole disciplinary lens or professional perspective. It should be thought of and 
addressed directly as both complex, systemic and distributed. However, this extended reach 
must not be allowed to elicit any diffusion of responsibility or dilution of expertise. Each 
discipline must excel within its own particular domain to enable the best possible 
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interdisciplinary and inter-professional solutions to be generated. We need more effective 
ways of communicating between our disciplines and professions to understand our distinct 
roles and contributions in relation to combating AMR.   
 
The role of health psychologists within AMR 
The contribution of health psychology is to demonstrate the value and significance of 
understanding the drivers of AMR from an individual, and typically, behaviour change 
perspective. At first glance this might appear antithetical to the complex systemic 
framework depicted earlier. However, each discipline and profession has its unique yet 
complementary role to play. From a psychological perspective the commonalities across the 
system and its plethora of stakeholders relates to the multiple embedded individuals who 
each represent a particular and often distinct lever for AMR-related behaviour change. 
What differentiates these individuals across the AMR system is the very particular locus of 
change: the exact target of behaviour change interventions.  
 
In this way, the same psychological perspectives can illuminate the very different decision-
making processes of, for example, government officials in changing the financial models 
underpinning drug development. Or equally leaders within Pharmaceutical companies who 
can be targeted to persuade and change the focus of their programme of drug 
development. Furthermore, psychological perspectives can be used to target the decision-
making of professional prescribers such as companion animal vets, nurse-led catheter care 
or indeed compliance with antibiotic prescriptions amongst the patient population. The 
commonality of psychological approach consistently focuses upon an analysis of i) which 
behaviours need to be changed (specifying a behavioural target) and; ii) an examination of 
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the antecedents of these particular behaviours (often as barriers and facilitators to changing 
the specific behavioural target). To oversimplify things, behaviour change interventions seek 
to change the particular antecedents of particular behaviours (so make most of the 
facilitators and respond where possible by removing barriers to behaviour change).  The 
process of intervention development, or much of implementation science, is about ensuring 
the right mixture of active components within behaviour change interventions.   Behaviour 
change interventions which tailor intervention components to the right antecedents of 
behaviour change, amongst the right people at the right time within the right context are 
most likely to be effective.  
 
In recent years health psychology has undergone profound and positive change in relation 
to how it thinks about its core business of understanding and intervening in relation to 
behaviour change. Historically the discipline has suffered from an unhealthy proliferation of 
broadly similar, yet slightly different, theoretical models each mapping models of the ways 
varied antecedents relate to behaviour and behaviour change. Classic health behaviour 
change models include, for example, the Health Belief Model (Becker, 1974), the Theory of 
Reasoned Action (Fishbein and Ajzen, 1975) or Social Learning theory (Bandura, 1977)  
Arguably this led to the discipline appearing to others as opaque at best and in a state of 
pointless inertia at worst.  
 
More recently, there has been a move to systematise the literally hundreds of behavioural 
models which exist and focus upon their similarities rather than their differences. In relation 
to the goal of interdisciplinary and inter-professional work, this simplification of theory 
clarifies the role of health psychology. It enables an easier inter-professional understanding 
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of what health psychology is, and health psychologists can offer. This is exactly what the 
threat of AMR demands. The behaviour change wheel (Michie et al., 2014) offers the most 
accessible framework to understanding how a psychological lens can illuminate behaviour 
and behaviour change. Its logic enables the systematic and specific development of 
intervention components to address the particular determinants of specific behaviours (e.g., 
compliance with all steps of hand hygiene versus the appropriate use of alcohol based hand 
rub by visitors to a hospital ward).  
 
At the heart of the behaviour change wheel is the familiar depiction of behaviour and its 
antecedents. In contrast to the several hundred antecedents of behaviour suggested across 
the many previous models of behaviour change the behaviour change wheel offers three 
major ways of characterising antecedents, capability, opportunity and motivation (the COM-
B model of behaviour change).  More nuanced ways of conceptualising antecedents are also 
available within the behaviour change wheel which characterise antecedents across the 
fourteen domains of the theoretical domains framework (Prestwich et al., 2014; Atkins et 
al., 2017).  
 
Broadly speaking intervention components are matched to each of the relevant 
antecedents. If the antecedents of GP’s issuing delayed prescriptions relate to issues of their 
capability then interventions that address capability are more likely to be effective. Equally, 
if the issue of storing antibiotics amongst the public relates primarily to their motivations to 
keeping antibiotics then interventions that target their motivations are likely to be effective.  
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There have also been considerable developments in the ways we can communicate the 
active components of behaviour change interventions. For example, the specification and 
communication of behaviour change techniques (BCTs) used within behaviour change 
interventions. The focus upon BCTs represents an attempt to develop a common language 
relating to key aspects of active intervention content. In turn this facilitates the 
development of cumulative knowledge and creates a better evidence base able to combat 
issues such as AMR. To date, 93 individual BCTs have been identified; these individual 
techniques are clustered into 16 distinct groups of behaviour change techniques(Michie et 
al., 2013; Michie et al., 2016) . Many of these behaviour change techniques will already be 
familiar to health professionals working within infection prevention and control and the 
wider field of AMR. The BCT taxonomy represents a major step forwards because it provides 
a common language rather than because it generates new techniques. Such shared 
vocabulary is central to addressing complex issues such as AMR where varied health 
professionals will be delivering interventions and utilising BCTs.  
 
These exciting developments within health psychology are of interest and relevance to 
combatting AMR for two main reasons. Firstly, within the discipline itself, they provide both 
clarity and consistency of the basic work of health psychologists. Such approaches will 
reduce un-necessary duplication of effort. Instead these developments will focus 
psychological contributions on applied work, developing and implementing effective 
interventions rather than reinventing explanatory frameworks. This shift in focus creates 
capacity to address AMR and other complex issues. Secondly, recent developments help 
health psychologists work more effectively with other disciplines and professionals. 
Establishing common understanding, and common language, relating to the basic function 
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of health psychology is an essential step in understanding its unique contribution and  also 
in illuminating its particular limitations.  
 
Conclusion 
Imaginative, innovative and interdisciplinary interventions are needed to reduce the drivers 
of AMR across the coming decades. This ambitious enterprise warrants the best of what 
each individual, discipline and profession can offer. There can be no dilution of particular 
expertise and contribution. However, the need for better interdisciplinary and inter-
professional work is not without its challenges. We need effective ways of communicating 
our relative expertise. A mutual understanding is needed in order to capitalise upon the 
synergies offered by different approaches working together. This is essential to enable the 
strengths in one approach to compensate for the weaknesses in others. In this way we need 
to create opportunities for connecting the best of health psychology with the best of 
medical sociology for example. The former has a clear focus upon the individual and their 
behaviour. In contrast the latter focuses on the systems and organisations in which such 
individual behaviours are embedded. We also need to understand and capitalise upon how 
diverse professions work together, what lessons concerning AMR can be learned and shared 
across prescribing (Vet, Nurse, and Medic). How can hospital based infection prevention and 
control illuminate veterinarian practice or the farmyard. It is only together, with genuine 
dialogue and collaboration that we can address the complexity and gravity of challenges 
posed by AMR. 
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